Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations Share Price rises 9.73% as stock gains today
- September 29, 2026
- Posted by: Kunal Singla
- Category: News
Syncom Formulations Share Price is Rs 24.36 today, up 9.73% from the previous close of Rs 22.20, with market capitalisation at Rs 1,885.64 crore. The latest Univest figures show a clear price rise in early trade, but no company-specific catalyst is established. For readers tracking Syncom Formulations Share Price Today, the move is notable because it lifts the stock into the day’s top gainers conversation while keeping the focus on verified price action, valuation and healthcare sector context. According to Univest data, the price event is confirmed, and the next useful checkpoints are the day’s range, valuation multiples and how the stock compares with listed pharmaceutical peers. Syncom Formulations Share Price News therefore centres on what changed in the market today rather than on any unverified trigger.
Syncom Formulations Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 24.36 |
| Previous Close | Rs 22.2 |
| Today's Move | Rs 2.16 (+9.73%) |
| Open | Rs 22.36 |
| High | Rs 24.85 |
| Low | Rs 22.06 |
| Market Capitalisation | Rs 1,885.64 crore |
| Market Cap Category | Small Cap |
Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 24.36 from the previous close of Rs 22.2, a move of Rs 2.16 or 9.73%. The stock opened at Rs 22.36, reached a high of Rs 24.85, recorded a low of Rs 22.06.
Syncom Formulations Share Price is trading at Rs 24.36, up Rs 2.16 or 9.73% from the previous close. The stock opened at Rs 22.36, touched a high of Rs 24.85 and a low of Rs 22.06, which places the current price near the upper end of today’s range. That is the core price action story behind Syncom Formulations Share Price today: a strong rise from the prior close, an opening above yesterday’s level and an intraday move that has stayed firm through the morning. Univest figures confirm the price action, but they do not point to a specific company trigger. For anyone following Syncom Formulations Share Price Live, the immediate reference points remain Rs 24.36, Rs 22.20 and the day’s range. The move also keeps Syncom Formulations Share Price in focus across Stock Market Today and Share Market Today screens. The next section shifts from price action to fundamental analysis.
Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,885.64 crore |
| P/E Ratio | 24.4x |
| P/B Ratio | 4.74x |
| ROE | 20.19% |
| ROCE | 26.8% |
| EPS | Rs 0.91 |
| Book Value Per Share | Rs 4.68 |
| Dividend Yield | 0.45% |
Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P/E 24.4x, P/B 4.74x, ROE 20.19%, ROCE 26.8%. Taken on their own, these numbers offer context rather than a trading signal.
Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1,885.64 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.4x, P/B at 4.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.45%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 24.4x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 4.74x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 20.19% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 26.8% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 1,885.64 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
Syncom Formulations (India) Ltd. (SYNCOMF) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 24.4x, which is below the benchmark median of 32.59x, a difference of -25.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.7%, a difference of +72.56%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.61%, a difference of +96.91%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 24.4x compared with the displayed peer median of 36.5x. The comparison is relative and should not be read as a recommendation. Its ROE of 20.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,885.64 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Syncom Formulations
- Syncom Formulations Share Price rose 9.73% today and is trading near the upper part of the day’s range.
- The latest Univest figures show PE, PB, ROE, ROCE, EPS, book value and dividend yield all in one view for Syncom Formulations Share Price.
- Syncom Formulations Share Price trades below the industry median PE but above the industry median PB in healthcare sector analysis.
- ROE and ROCE for Syncom Formulations Share Price are above the industry median, which adds context to the move.
- Syncom Formulations Stock News is also relevant because the stock is moving without a verified company-specific catalyst.
About Syncom Formulations
Syncom Formulations Share Price represents Syncom Formulations (India) Ltd., a company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business context matters because Syncom Formulations Share Price is often read through the lens of company overview, company financials and sector analysis rather than only through one trading move. The company operates in pharmaceuticals and drugs, which places it in an industry where valuation, return ratios and market capitalisation are closely watched. Syncom Formulations Share Price today reflects that broader setup: a smaller listed pharmaceutical company with measurable profitability ratios, a defined sector position and active comparison against listed peers. For readers following Syncom Formulations Stock Analysis, the company’s identity, industry and return profile are the main reference points available from Univest. That makes Syncom Formulations Share Price useful for investors who want a factual update on the stock without speculation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Syncom Formulations Share Price rising today?
Ans. Syncom Formulations Share Price is rising today because the stock is up 9.73% to Rs 24.36. Univest figures confirm the price action, but they do not point to a specific company trigger.
What is Syncom Formulations Share Price today?
Ans. Syncom Formulations Share Price today is Rs 24.36. It is higher than the previous close of Rs 22.20 and has moved within a day’s range of Rs 22.06 to Rs 24.85.
How much did Syncom Formulations Share Price gain today?
Ans. Syncom Formulations Share Price gained Rs 2.16, which is a 9.73% rise from the previous close. That makes it one of the sharper price moves in today’s market update.
What is Syncom Formulations Share Price market capitalisation?
Ans. Syncom Formulations Share Price has a market capitalisation of Rs 1,885.64 crore. That places the company above the industry median market cap of Rs 783.26 crore in the same industry benchmark.
Is Syncom Formulations Share Price expensive compared with peers?
Ans. Syncom Formulations Share Price trades at a PE of 24.4 and PB of 4.74. Its PE is below several major peers, while PB is above the industry median, so valuation needs a ratio-by-ratio view.
What does Syncom Formulations Share Price fundamental analysis show?
Ans. Syncom Formulations Share Price shows ROE of 20.19%, ROCE of 26.8%, EPS of Rs 0.91, book value of Rs 4.68 and dividend yield of 0.45%, which together frame the fundamental view.
How does Syncom Formulations Share Price compare with the sector?
Ans. Syncom Formulations Share Price has a PE below the industry median and ROE and ROCE above the industry median. That combination gives the stock a different profile within Healthcare and Pharmaceuticals & Drugs.
Should investors track Syncom Formulations Share Price now?
Ans. Investors tracking Syncom Formulations Share Price may watch how the current rise holds against the day’s range, valuation ratios and peer comparison. Univest keeps the latest numbers together for quick review.
Track Syncom Formulations Share Price on Univest
Use Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors tracking Syncom Formulations Share Price can use Univest to monitor live share price, market capitalisation, fundamental ratios, 52-week levels and market insights in one place. Syncom Formulations Share Price Today can be reviewed alongside PE, PB, ROE, ROCE, EPS, book value and dividend yield, which helps readers compare price action with company financials. Univest also keeps Syncom Formulations Stock News and Syncom Formulations Share News in a single research view for quick reference.
